Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,691,430
+$2,275,031 QoQ
Shares Held
150,627
+8.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#286
of 2,098 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BRAIDWELL LP holds $238,238,242 across 8 Diagnostics & Research names. DHR ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NEO |
Neogenomics Inc
|
4,918,202 | $71,756,567 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
89,395 | $44,819,077 | |
| 3 | CDNA |
CareDx, Inc.
|
1,220,602 | $34,787,157 | |
| 4 | DHR |
Danaher Corp /De/
This page
|
150,627 | $28,691,430 | |
| 5 | GH |
Guardant Health, Inc.
|
147,850 | $22,181,935 | |
| 6 | NTRA |
Natera, Inc.
|
79,500 | $21,580,275 | |
| 7 | DGX |
Quest Diagnostics Inc
|
43,200 | $9,156,240 | |
| 8 | WAT |
Waters Corp /De/
|
14,040 | $5,265,561 |
All Filings in DHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,691,430 | 150,627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,416,399 | 139,327 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,064,524 | 118,227 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $61,329,550 | 309,339 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,106,826 | 309,339 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,414,495 | 309,339 | Shares | Sole | 2025-05-15 | |
| 2023-09-30 | $19,153,319 | 77,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,296,002 | 55,400 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||